Ming Bioventures
Jiangsumingbioventures.com
Overview
Ming Bioventures is a venture capital firm founded in 2018. Based in Suzhou, China, the firm focuses on early-stage investments in the life science sectors, including innovative drugs, medical devices, emerging biotechnology, and medical diagnostics.
Portfolio Companies
7
Website
mingbioventures.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Innovo Therapeutics | Dec 2023 | Seed | Co-investor |
| Beyang Therapeutics Co., Ltd. | Jul 2023 | Pre Seed | Lead |
| Beyond Pharmaceutical Co., Ltd. | Jul 2023 | VC Round | Lead |
| Tyligand Bioscience | Nov 2022 | Series A Extension | Lead |
| Innovo Therapeutics | May 2022 | Angel | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
